Summary by Moomoo AI
Aditxt, Inc., a biotech company listed in the United States, has achieved a regulatory milestone with the Securities and Exchange Commission (SEC). The SEC has declared the company's Form S-1 effective as of June 13, 2024, at 5:00 PM. This form is typically used by companies to register new securities for sale to the public, indicating that Aditxt may be preparing to offer new shares. The effectiveness of the Form S-1 is a crucial step in the process, allowing the company to proceed with the public offering.